MicroRNA mimetic for use in cancer treatment

Specific microRNA mimetics like miR-323a, miR-3127, and miR-3161, alone or in combination, provide effective inhibition of tumor cell survival and proliferation, addressing the limitations of existing mimetics in cancer treatment.

FR3169480A1Pending Publication Date: 2026-06-12UNIV CLAUDE BERNARD LYON 1 +3
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
FR2024013698
Authority / Receiving Office
FR · FR
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-12-09
Publication Date
2026-06-12

Smart Images

  • Figure 00000023_0000
    Figure 00000023_0000
  • Figure 00000023_0001
    Figure 00000023_0001
  • Figure 00000024_0000
    Figure 00000024_0000
Patent Text Reader

Abstract

The invention relates to a microRNA mimetic or a combination of microRNA mimetics, for use in the prevention and / or treatment of cancer in a patient, said microRNA mimetic being selected from a miR323a, miR3127 and / or miR3161 mimetic, alone or in combination.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Mirna combination for the prevention and treatment of cancer

    WO2023052372A1